Stop looking for answers,
innovate with the right partner

Seeking soil health solutions which reduce the reliance on synthetic agrochemicals applied to and/or improve soil health whilst maintaining yield and quality

• Posted by PepsiCo
• ·
• Project Size : 250,000 - 1,000,000 €

Nitrogen is a key requirement for crop growth and building healthy soil supports sustainable crop production. The aim of this project is to identify and validate microbiome technologies which reduce the reliance on synthetic agrochemicals applied to and/or improve soil health in potato, oat, citrus and corn crops, whilst maintaining yield and quality.

Seeking Collaboration To Understand Phenomenon Leading To The Creation Of 3-MCPD's In Pre Fried Food Products

• Posted by Nomad Foods
• ·
• Project Size : Strategic project backed by large scale funding €

Seeking Collaboration to understand phenomenon leading to the creation of 3-MCPD in pre fried food products and implement solutions to limit and control their level in pre-fried foods. We are looking to collaborate with individuals, companies or academic institutions: - to develop our knowledge of the parameters leading to the creation of 3-MCPD esters in our industrial conditions - assess the impact of time vs temperature in the 3-MCPDs esters creation - to develop predictive models & lab scale test methods to facilitate product design, assess risk & define processing parameters - impact of mono and diacylglycerols in oil before cooking - to develop quick and reliable methods that would allow to measure (directly or indirectly) 3-MCPD levels in the frying oil - to implement process-control solutions at the industrial scale, preferably within a 2 year timeframe Nature of collaboration is to be negotiated.

Seeking Acid and Heat Stable Sweet Proteins

• Posted by PepsiCo
• ·
• Deadline : 2024-07-04

Description PepsiCo seeks high-intensity sweet proteins (e.g., Brazzein, Monellin, Thaumatin) that are stable in low pH environments and during thermal treatments in ready-to-drink, shelf-stable beverage applications. Background The area of sugar reduction continues to be of high interest to PepsiCo and the search for novel sweeteners and technologies to reformulate, grow, and protect core brands by achieving consumer acceptance in a cost-effective manner.

Process for converting waste, effluents and organic by-products in recyclable materials

• Posted by UACOOPERA University of Aveiro from uacoopera
• ·
• Patents for licensing

Biological process to treat waste, effluents and organic by-products with industrial origin characterized by high biodegradability. This process adds value to convention-al biological treatment processes, integrating their assumptions on the concept of biorefinery, simultaneously allowing reducing and eliminating organic matter and incorporating organic components in added-value mate-rials (lipids, gases with energetic potential, volatile organic acids and polyhydroxyalkanoates (PHA), instead of discharging as primary products to the environment. The invention aims to reduce by 96% the organic matter content of the starting substrate allowing generally meet the discharge criteria set out in the legislation.

Automated Tumour-Stroma Interface Zone Detection for Anti-Tumour Response Assessment by Immunogradient Indicators

• Posted by Vilnius University
• ·
• Knowhow and Research output

The Immunogradient indicators are aimed at assessing tissue immune response properties in the context of tumour microenvironment and has a potential for prognostic/predictive biomarkers in cancer patients.

Circular RNA biomarkers for heart failure diagnostics

• Posted by Jeremie Langlet from Luxembourg Institute of Health
• ·
• Patents for licensing

Circular RNAs are a class of noncoding RNAs covalently closed by a back spicing event, making them protected from degradation by exonuclease. They are tissue- and disease-specific and are detectable in the blood. These properties confer circRNAs with valuable potential as disease biomarkers for diagnostic and therapeutic purposes. The Cardiovascular Research team of the Luxembourg Institute of Health leaded by Dr Yvan Devaux has discovered and patented hundreds of circRNAs detectable in the blood and associated with cardiovascular conditions such as heart failure. Heart failure affects more than half of the population over 65 and represents an enormous financial burden to the society. Circular RNAs can be measured in a highly specific manner using sequencing, methods based on probe hybridization, or quantitative PCR with divergent primers. They have potential to be used in diagnostics tests, companion diagnostics or, being involved in disease development and progression, as therapeutic targets.